{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:54:46Z","timestamp":1792803286824,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.fertnstert.2024.03.026","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T08:40:33Z","timestamp":1714725633000},"page":"406-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fertility drugs and cancer: a guideline"],"prefix":"10.1016","volume":"122","member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.03.026_bib1","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.fertnstert.2016.08.035","article-title":"Fertility drugs and cancer: a guideline","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2013.01.027","article-title":"In\u00a0vitro fertilization is associated with an increased risk of borderline ovarian tumours","volume":"129","author":"Stewart","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/humrep\/deq307","article-title":"Malignancies among women who gave birth after in\u00a0vitro fertilization","volume":"26","author":"K\u00e4ll\u00e9n","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib4","first-page":"645","article-title":"Infertility and risk of fatal ovarian cancer in a prospective cohort of US women","volume":"9","author":"Rodriguez","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib5","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.fertnstert.2013.08.008","article-title":"Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort","volume":"100","author":"Trabert","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-12-0426","article-title":"Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study","volume":"21","author":"Kurta","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0015-0282(16)58557-4","article-title":"Ovulation induction, infertility, and ovarian cancer risk","volume":"66","author":"Bristow","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib8","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Australian Cancer Study Group (ovarian cancer), Australian Ovarian Cancer Study Group. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis","volume":"122","author":"Jordan","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/humupd\/dmaa045","article-title":"Endometriosis and cancer: a systematic review and meta-analysis","volume":"27","author":"Kvaskoff","year":"2021","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/aje\/kwi046","article-title":"Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis","volume":"161","author":"Tung","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2006.11.014","article-title":"LH\/hCG action and development of ovarian cancer--a short review on biological and clinical\/epidemiological aspects","volume":"269","author":"Mandai","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcp.10401","article-title":"Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium","volume":"198","author":"Stewart","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/gyno.1993.1141","article-title":"Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells","volume":"49","author":"Kikuchi","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.fertnstert.2015.07.1135","article-title":"Cancer in women after assisted reproductive technology","volume":"104","author":"Luke","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib18","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/humrep\/dez165","article-title":"Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study","volume":"34","author":"Vassard","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-019-05358-8","article-title":"Endometriosis and risk of ovarian cancer: what do we know?","volume":"301","author":"Kr\u00e1l\u00ed\u010dkov\u00e1","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00432-015-2035-x","article-title":"The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up","volume":"142","author":"Kessous","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib21","article-title":"Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation","volume":"362","author":"Williams","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10654-019-00540-3","article-title":"Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study","volume":"34","author":"Lundberg","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib23","first-page":"CD008215","article-title":"Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility","volume":"6","author":"Rizzuto","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib24","first-page":"CD008215","article-title":"Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility","volume":"2013","author":"Rizzuto","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2015.02.011","article-title":"Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers","volume":"103","author":"Perri","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/humrep\/dev324","article-title":"Short- and long-term health consequences and current satisfaction levels for altruistic anonymous, identity-release and known oocyte donors","volume":"31","author":"S\u00f6derstr\u00f6m-Anttila","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib27","series-title":"PDQ cancer information summaries","article-title":"Ovarian low malignant potential tumors treatment (PDQ\u00ae): health professional version","year":"2002"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib28","first-page":"116","article-title":"[WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics]","volume":"86","author":"B\u00f6cker","year":"2002","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumors in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/aje\/155.3.217","article-title":"Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies","volume":"155","author":"Ness","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib31","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","article-title":"Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden","volume":"91","author":"Sanner","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib32","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in\u00a0vitro fertilization in a large Dutch cohort","volume":"26","author":"van Leeuwen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib33","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.fertnstert.2005.08.061","article-title":"Induction of ovulation and ovarian cancer: a critical review of the literature","volume":"85","author":"Mahdavi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/gyno.1997.4928","article-title":"Treatment for fertility and risk of ovarian tumors of borderline malignancy","volume":"68","author":"Parazzini","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(16)58020-0","article-title":"Human menopausal gonadotropin and the risk of epithelial ovarian cancer","volume":"65","author":"Shushan","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0015-0282(98)00337-9","article-title":"Ovarian stimulation and borderline ovarian tumors: a case-control study","volume":"70","author":"Mosgaard","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/09513590701350341","article-title":"Ovulation induction treatment and risk of borderline ovarian tumors","volume":"23","author":"Cusid\u00f3","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/humrep\/deu297","article-title":"Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study","volume":"30","author":"Bj\u00f8rnholt","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2015.12.005","article-title":"Treatment of infertility and the risk of ovarian cancer: are the data reassuring?","volume":"105","author":"Paulson","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra050776","article-title":"Estrogen carcinogenesis in breast cancer","volume":"354","author":"Yager","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/1389557511313050002","article-title":"Regulation of gene expression by progesterone in cancer cells: effects on cyclin D1, EGFR and VEGF","volume":"13","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.steroids.2012.11.003","article-title":"Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2","volume":"78","author":"Diaz Flaqu\u00e9","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib43","first-page":"437","article-title":"Treatment with human chorionic gonadotropin and risk of breast cancer","volume":"4","author":"Bernstein","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib44","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","article-title":"Risk of cancer after use of fertility drugs with in-vitro fertilisation","volume":"354","author":"Venn","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","article-title":"In\u00a0vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services","volume":"99","author":"Brinton","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","article-title":"Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies","volume":"150","author":"Gennari","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/ijc.29069","article-title":"Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway","volume":"136","author":"Reigstad","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib48","first-page":"8042","article-title":"Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors","volume":"22","author":"Del Pup","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib49","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.ejca.2015.05.007","article-title":"Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome","volume":"51","author":"Goldrat","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib50","first-page":"107","article-title":"Fertility drugs and breast cancer risk","volume":"36","author":"Lo Russo","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clbc.2018.03.003","article-title":"Breast cancer and ovulation induction treatments","volume":"18","author":"Taheripanah","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09513590.2012.671391","article-title":"Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up","volume":"28","author":"Lerner-Geva","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1472-6483(10)60689-X","article-title":"Long-term effects of ovulation-stimulating drugs on cancer risk","volume":"15","author":"Brinton","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib54","first-page":"1681","volume":"164","author":"Levine","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib55","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<928::AID-IJC22>3.0.CO;2-W","article-title":"Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells","volume":"77","author":"Lavie","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/aogs.12393","article-title":"Serum concentrations of HE4 change little during in\u00a0vitro fertilization","volume":"93","author":"Hallamaa","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwn318","article-title":"Cancer risk after exposure to treatments for ovulation induction","volume":"169","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(01)02986-7","article-title":"Cancer incidence in a cohort of infertile women who underwent in\u00a0vitro fertilization","volume":"77","author":"Dor","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib59","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/oxfordjournals.aje.a009397","article-title":"Cancer incidence in a cohort of infertile women","volume":"147","author":"Modan","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib60","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(99)00085-0","article-title":"Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study","volume":"71","author":"Potashnik","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib61","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/oxfordjournals.aje.a114595","article-title":"Cancer incidence in a cohort of infertile women","volume":"125","author":"Ron","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib62","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort","volume":"100","author":"dos Santos Silva","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/00016349709050077","article-title":"Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases","volume":"76","author":"Unkila-Kallio","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(95)91687-3","article-title":"Breast and ovarian cancer incidence after infertility and in\u00a0vitro fertilisation","volume":"346","author":"Venn","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/gyno.2001.6209","article-title":"Characteristics of ovarian and uterine cancers in a cohort of in\u00a0vitro fertilization patients","volume":"82","author":"Venn","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fertnstert.2004.09.016","article-title":"Ovulation induction and cancer risk","volume":"83","author":"Brinton","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib67","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","article-title":"Cancer incidence following treatment for infertility at a clinic in the UK","volume":"17","author":"Doyle","year":"2002","journal-title":"Hum Reprod"},{"issue":"72","key":"10.1016\/j.fertnstert.2024.03.026_bib68","first-page":"e1","article-title":"Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study","volume":"200","author":"Org\u00e9as","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib69","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/HUMREP\/11.2.300","article-title":"Fertility treatment and risk of breast cancer","volume":"11","author":"Braga","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib70","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/deh371","article-title":"Breast cancer risk associated with ovulation-stimulating drugs","volume":"19","author":"Brinton","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib71","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1055-9965.EPI-13-0996","article-title":"Long-term relationship of ovulation-stimulating drugs to breast cancer risk","volume":"23","author":"Brinton","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib72","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(02)04950-6","article-title":"Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study","volume":"79","author":"Burkman","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib73","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jnci\/djs255","article-title":"Fertility drugs and young-onset breast cancer: results from the Two Sister Study","volume":"104","author":"Fei","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib74","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/humrep\/deh422","article-title":"E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study","volume":"19","author":"Gauthier","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib75","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1158\/1055-9965.EPI-07-0075","article-title":"Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study","volume":"16","author":"Jensen","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/humrep\/del411","article-title":"Tumour incidence in Swedish women who gave birth following IVF treatment","volume":"22","author":"Kristiansson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib77","first-page":"1111","article-title":"Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study","volume":"19","author":"Kotsopoulos","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib78","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1245\/s10434-007-9800-2","article-title":"The possible association between IVF and breast cancer incidence","volume":"15","author":"Pappo","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib79","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/humrep\/14.6.1653","article-title":"Fertility drugs and the risk of breast cancer","volume":"14","author":"Ricci","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib80","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1996.0002","article-title":"Risk of breast cancer in a cohort of infertile women","volume":"60","author":"Rossing","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib81","first-page":"259","article-title":"In\u00a0vitro fertilization and breast cancer risk: a review","volume":"50","author":"Salhab","year":"2005","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/humupd\/dmt034","article-title":"IVF and breast cancer: a systematic review and meta-analysis","volume":"20","author":"Sergentanis","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib83","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fertnstert.2012.04.019","article-title":"In\u00a0vitro fertilization and breast cancer: is there cause for concern?","volume":"98","author":"Stewart","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.rbmo.2010.05.006","article-title":"Breast cancer diagnosis following ovarian stimulation: are the tumours different?","volume":"21","author":"S\u00f6nmezer","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib85","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1001\/archinte.166.22.2484","article-title":"A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer","volume":"166","author":"Terry","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib86","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.fertnstert.2017.05.010","article-title":"Ovarian stimulation and risk of breast cancer in Swedish women","volume":"108","author":"Lundberg","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib87","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5935\/1518-0557.20170026","article-title":"Do women offered assisted reproduction technologies have a higher incidence of gynecologic cancer? A systematic review and meta-analysis","volume":"21","author":"Schwarze","year":"2017","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib88","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/IGC.0b013e318277608b","article-title":"Meta-analysis on the possible association between in\u00a0vitro fertilization and cancer risk","volume":"23","author":"Li","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-010-1140-4","article-title":"Fertility drugs and the risk of breast cancer: a meta-analysis and review","volume":"124","author":"Zreik","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib90","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/humrep\/des031","article-title":"Cancer morbidity in a cohort of 9175 Finnish women treated for infertility","volume":"27","author":"Yli-Kuha","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib91","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.2016.9389","article-title":"Ovarian stimulation for in\u00a0vitro fertilization and long-term risk of breast cancer","volume":"316","author":"van den Belt-Dusebout","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib92","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.fertnstert.2019.10.007","article-title":"Influence of subfertility and assisted reproductive technology treatment on mortality of women after delivery","volume":"113","author":"Coddington","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib93","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/humrep\/dez018","article-title":"Risk of cancer in infertile women: analysis of US claims data","volume":"34","author":"Murugappan","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib94","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-006-9238-4","article-title":"Infertility, ovulation induction treatments and the incidence of breast cancer\u2014a historical prospective cohort of Israeli women","volume":"100","author":"Lerner-Geva","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib95","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1524-4741.2008.00641.x","article-title":"Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study","volume":"14","author":"Katz","year":"2008","journal-title":"Breast J"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwi084","article-title":"Uterine cancer after use of clomiphene citrate to induce ovulation","volume":"161","author":"Althuis","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib97","first-page":"319","article-title":"Cancer risk associated with subfertility and ovulation induction: a review","volume":"11","author":"Klip","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib98","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejogrb.2015.09.002","article-title":"Does fertility treatment increase the risk of uterine cancer? A meta-analysis","volume":"195","author":"Saso","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib99","first-page":"CD010931","article-title":"Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility","volume":"3","author":"Skalkidou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/WHE.14.58","article-title":"Long-term cancer risks in women after treatment with IVF: do we have any answers yet?","volume":"11","author":"Stewart","year":"2015","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib101","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/humrep\/dem381","article-title":"Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study","volume":"23","author":"Hannibal","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7191704","article-title":"Fertility drugs associated with thyroid cancer risk: a systematic review and meta-analysis","volume":"2018","author":"Yu","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib103","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.fertnstert.2015.06.045","article-title":"Effects of fertility drugs on cancers other than breast and gynecologic malignancies","volume":"104","author":"Brinton","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib104","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ajog.2005.01.091","article-title":"Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs","volume":"193","author":"Althuis","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib105","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cgh.2015.12.018","article-title":"Risk of colorectal cancer after ovarian stimulation for in\u00a0vitro fertilization","volume":"14","author":"Spaan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib106","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/humrep\/dev124","article-title":"Cancer risk among parous women following assisted reproductive technology","volume":"30","author":"Reigstad","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/humupd\/dms051","article-title":"Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis","volume":"19","author":"Siristatidis","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ijgc-00009577-200301000-00004","article-title":"The possible association between in\u00a0vitro fertilization treatments and cancer development","volume":"13","author":"Lerner-Geva","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib109","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(16)58021-2","article-title":"In situ and invasive cervical carcinoma in a cohort of infertile women","volume":"65","author":"Rossing","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib110","first-page":"1393","article-title":"A potential pathogenic link between cancer of female reproductive system and infertile women treated with assisted reproduction techniques","volume":"35","author":"Diakosavvas","year":"2021","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib111","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","article-title":"Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis","volume":"36","author":"Barcroft","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib112","first-page":"759","article-title":"Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study","volume":"19","author":"Hannibal","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib113","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41416-019-0411-z","article-title":"Reproductive factors, exogenous hormone use and incidence of melanoma among women in the United States","volume":"120","author":"Donley","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib114","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/oxfordjournals.aje.a117361","article-title":"Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use","volume":"141","author":"Holly","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00008390-199504000-00009","article-title":"Risk of cutaneous melanoma in a cohort of infertile women","volume":"5","author":"Rossing","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib116","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/humrep\/dev023","article-title":"Melanoma risk after ovarian stimulation for in\u00a0vitro fertilization","volume":"30","author":"Spaan","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib117","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.1007\/s13277-014-2230-4","article-title":"Correlation between fertility drugs use and malignant melanoma incidence: the state of the art","volume":"35","author":"Tomao","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib118","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008390-200110000-00015","article-title":"A study of infertility treatment and melanoma","volume":"11","author":"Young","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1016\/j.fertnstert.2024.03.026_bib119","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/CMR.0000000000000019","article-title":"Association between in-vitro fertilization, birth and melanoma","volume":"23","author":"Stewart","year":"2013","journal-title":"Melanoma Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224002012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224002012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:51:48Z","timestamp":1756687908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0015028224002012"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.03.026","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility drugs and cancer: a guideline","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}